The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling

Yunkai Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Wang(Capital Medical University), Baowen Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Tianyu Ma(Xuzhou Medical College), Hefen Yu(Capital University), Miaomiao Huo(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Zhang(Sichuan University), Wei Liu(Guangxi Academy of Sciences), Tianyang Gao(Shandong First Medical University), Wei Huang(Capital Medical University), Xinhui Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingyao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ting Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Teng Xu(Fudan University)
Cancer Letters
August 8, 2024
Cited by 18


Related Papers